Back to Wyoming

HB0293 • 2005

Illegal drug manufacturing-precursor chemicals.

AN ACT relating to controlled substances; regulating the sale of illegal drug precursors as specified; prohibiting sales to minors; providing penalties; and providing for an effective date.

Crime
Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Representative Harvey
Last action
2005-03-15
Official status
enrolled
Effective date
7/1/2005

Plain English Breakdown

The plain English breakdown is still being put together. The official documents below are already here.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

HB0293HW001

Committee of the Whole • HARVEY

Adopted, Corrected

Plain English: Adopted, Corrected Committee of the Whole by HARVEY

  • This amendment summary is using official source text because generated interpretation was skipped for this run.
  • The official amendment text was available, but an easy plain-English summary could not be produced automatically during the last sync.
HB0293HS001

Standing Committee • H10

Adopted

Plain English: Adopted Standing Committee by H10

  • This amendment summary is using official source text because generated interpretation was skipped for this run.
  • The official amendment text was available, but an easy plain-English summary could not be produced automatically during the last sync.
HB0293S2001

2nd reading • JENNINGS

Failed

Plain English: Failed 2nd reading by JENNINGS

  • This amendment summary is using official source text because generated interpretation was skipped for this run.
  • The official amendment text was available, but an easy plain-English summary could not be produced automatically during the last sync.
HB0293S3001

3rd reading • JENNINGS

Failed

Plain English: Failed 3rd reading by JENNINGS

  • This amendment summary is using official source text because generated interpretation was skipped for this run.
  • The official amendment text was available, but an easy plain-English summary could not be produced automatically during the last sync.
HB0293SS001

Standing Committee • SCOTT

Adopted

Plain English: Adopted Standing Committee by SCOTT

  • This amendment summary is using official source text because generated interpretation was skipped for this run.
  • The official amendment text was available, but an easy plain-English summary could not be produced automatically during the last sync.

Bill History

  1. 2005-03-15 LSO

    Assigned Chapter Number - 246

  2. 2005-03-15 Governor

    Governor Signed HEA0133

  3. 2005-03-03 Senate

    S President Signed HEA No. 0133

  4. 2005-03-03 House

    H Speaker Signed HEA No. 0133

  5. 2005-03-02 LSO

    Assigned Number HEA0133

  6. 2005-03-02 Senate

    S Adopted HB0293JC01

  7. 2005-03-01 House

    H Adopted HB0293JC01

  8. 2005-02-25 House

    H Appointed JCC01 Members

  9. 2005-02-24 Senate

    S Appointed JCC01 Members

  10. 2005-02-23 House

    H Did Not Concur

  11. 2005-02-23 Senate

    S Passed 3rd Reading

  12. 2005-02-23 Senate

    Amendment Failed

  13. 2005-02-22 Senate

    S Passed 2nd Reading

  14. 2005-02-22 Senate

    Amendment Failed

  15. 2005-02-18 Senate

    S Passed CoW

  16. 2005-02-18 Senate

    S Amendments Adopted

  17. 2005-02-17 Senate

    S Placed on General File

  18. 2005-02-17 Senate

    S10 Recommended Amend and Do Pass

  19. 2005-02-08 Senate

    S Introduced and Referred to S10

  20. 2005-02-04 Senate

    S Received for Introduction

  21. 2005-02-03 House

    H Passed 3rd Reading

  22. 2005-02-02 House

    H Passed 2nd Reading

  23. 2005-02-01 House

    H Passed CoW

  24. 2005-02-01 House

    Amendment Adopted

  25. 2005-02-01 House

    Amendment Adopted

  26. 2005-02-01 House

    H Amendments Adopted

  27. 2005-01-25 House

    H Placed on General File

  28. 2005-01-25 House

    H10 Recommended Amend and Do Pass

  29. 2005-01-21 House

    H Introduced and Referred to H10

  30. 2005-01-21 House

    H Received for Introduction

  31. 2005-01-20 LSO

    Bill Number Assigned

Official Summary Text

2005 General Session Summary for HB0293

Bill
No.:
HB0293
Drafter:

JWL

LSO
No.:
05LSO-0585
Effective Date:

7/1/2005

Enrolled
Act No.:
HEA0133

Chapter
No.:
246

Prime
Sponsor:
Representative Harvey

Catch Title:
Illegal drug
manufacturing-precursor chemicals.

Subject:
Regulates the sale of drugs
containing
methamphetamine precursor chemicals.

Summary/Major
Elements:

This act:

Makes possession of a drug product containing more than
15 grams of specified methamphetamine precursors a felony (5 years/$25,000 or
both), except the felony provision does not apply to: retailers, wholesalers,
manufacturers and pharmacists licensed by the Board of Pharmacy; licensed
health care professionals in the course of practicing their profession;
household storage consistent with medicinal or household use.

Limits sale of specified non-liquid methamphetamine
precursors to two packages containing less than three grams of specified
precursors or sale in blister packs containing no more than two doses per
blister.

Requires retailers to sell products containing
methamphetamine precursors from behind a counter, from a locked display case,
from an alarm-protected display or a display under video surveillance.

Makes intentional or knowing violation of sales
restrictions a misdemeanor, with increased penalties for subsequent violations.

Requires retailers, manufacturers and wholesalers of
specified methamphetamine precursors to register with the Board of Pharmacy,
report specified information to the Board and be subject to inspection for
enforcement of this act.

Authorizes the Board to revoke or suspend a license, or
impose an administrative penalty of $100 (first offense), $500 (second offense
within two years) or $1,000 (third offense within three years).

Current Bill Text

Read the full stored bill text
WORKING DRAFT

ORIGINAL HOUSE

BILL

NO.
0293

ENROLLED ACT NO. 133, HOUSE OF REPRESENTATIVES

FIFTY-EIGHTH LEGISLATURE OF THE STATE OF WYOMING
2005 GENERAL SESSION

AN ACT relating to controlled substances; regulating the sale of illegal drug precursors as specified; prohibiting sales to minors; providing a definition; providing penalties; and providing for an effective date.

Be It Enacted by the Legislature of the State of Wyoming:

Section 1.
W.S. 35
‑
7
‑
1059 by creating new subsections (e) through (p) is amended to read:

35
‑
7
‑
1059.

Unlawful clandestine laboratory operations; methamphetamine precursors; presumptively illegal amount; methamphetamine precursor sales limitations; registration requirements; reports; penalties.

(e)

Except as provided in this subsection, no person shall possess a drug product containing more than fifteen (15) grams of ephedrine, pseudoephedrine or phenylpropanolamine, or their salts, isomers or salts of isomers. This subsection shall not apply to the following persons who are lawfully possessing drug products in the course of legitimate business:

(i)

A retail distributor or wholesaler of drug products registered with the board;

(ii)

A wholesale drug distributor licensed by the board;

(iii)

A drug manufacturer licensed by the board;

(iv)

A pharmacist licensed by the board;

(v)

A licensed health care professional possessing the drug products in the course of practicing his profession;

(vi)

A person in possession of more than fifteen (15) grams of methamphetamine precursor drugs in the person's home or residence under circumstances consistent with typical medicinal or household use as indicated by, but not limited to, storage location and possession of products in a variety of strengths, brands, types, purposes and expiration dates.

(f)

A person who knowingly or intentionally violates subsection (e) of this section is guilty of a felony punishable by imprisonment for not more than fifteen (15) years, a fine of twenty-five thousand dollars ($25,000.00), or both.

(g)

The retail sale of nonliquid methamphetamine precursor drugs or liquid products with ephedrine or pseudoephedrine as the sole active ingredient shall be limited to:

(i)

Sales in packages containing not more than three (3) grams of one (1) or more methamphetamine precursor drugs, calculated in terms of the active equivalent of ephedrine hydrochloride and pseudoephedrine base;

(ii)

Sales in blister packs, each blister containing not more than two (2) dosage units or, when the use of blister packs is not technically feasible, sales in unit dose packets or pouches.

(h)

No person shall sell in a single retail transaction more than two (2) packages as described in subsection (f) of this section.

(j)

A retail distributor of products containing methamphetamine precursors shall sell them in one (1) of the following ways:

(i)

Product packages are displayed behind a store counter, in an area not accessible to customers;

(ii)

Product packages are displayed in a locked case so that a customer must ask a store employee for assistance in purchasing the product;

(iii)

Product packages are displayed within thirty (30) feet of and in the direct line of sight of a cash register or store counter staffed by a store employee and the store employs a reliable alarm system to prevent the theft of multiple product packages;

(iv)

Product packages are displayed in a location that is under constant video surveillance and:

(A)

Persons examining or removing packages are within the camera's view;

(B)

The video camera records recognizable images at least once every ten (10) seconds;

(C)

Surveillance images are preserved for at least one hundred sixty-eight (168) hours and are available to law enforcement authorities immediately upon request;

(D)

The retail distributor posts a sign in a prominent manner stating that the area is under constant video surveillance;

(E)

The retail distributor reports to local law enforcement any theft or suspected thefts.

(k)

A person who intentionally or knowingly violates subsection (g), (h) or (j) of this section is guilty of a misdemeanor punishable by a fine of one hundred dollars ($100.00) for a first offense, five hundred dollars ($500.00) for a second offense within two (2) years and one thousand dollars ($1,000.00) and up to six (6) months imprisonment, or both, for a third offense within three (3) years. It shall be a defense to violation under paragraph (g)(ii) of this section that the person making the sale required and obtained proof of age from a purchaser who produced a false, forged or altered document that an ordinarily prudent person would believe to be legitimate.

(m)

A resident or nonresident retailer, manufacturer or wholesaler who distributes ephedrine, pseudoephedrine or phenylpropanolamine, or their salts, isomers or salts of isomers in Wyoming shall:

(i)

Register with the board by submitting an application on a form prescribed by the board and pay a registration fee of twenty-five dollars ($25.00). Where the retailer, manufacturer or wholesaler distributions are conducted at more than one (1) location, each location shall be separately registered. Except as provided in subsection (m) of this section, those facilities registered with the board under W.S. 35
‑
7
‑
1024 on July 1, 2005, shall not be required to register under this section;

(ii)

Notify the board of the occurrence of any of the following:

(A)

The permanent closing of the retailer, manufacturer or wholesaler outlet;

(B)

A change in ownership, name, management or location.

(iii)

Be subject to inspection by the board. Inspections shall be conducted during normal business hours and shall be limited to the following:

(A)

For retail distribution, inspection of the method of display and sale of any drug products covered by this section;

(B)

For manufacturer or wholesaler distribution, inspection of the purchase and sale records of any drug products covered by this section.

(iv)

Display the registration issued by the board in a conspicuous location in the place of business;

(v)

Provide reports to the board as follows:

(A)

A manufacturer or wholesaler who distributes drug products covered by this section shall submit a monthly report no later than the 10
th
day of the month immediately following the month in which the distribution takes place;

(B)

The report shall include a listing by retail vendor, including the name of the proprietary product, package size, date shipped and quantity shipped.

(n)

A registration issued under this section shall be renewed annually, on or before September 30, by submitting a renewal application supplied by the board and paying the renewal fee of twenty-five dollars ($25.00). Renewal applications postmarked after September 30 shall be subject to a late fee of fifty dollars ($50.00) which shall be in addition to the renewal fee.

(o)

The board may revoke, suspend or assess an administrative penalty for violations of subsection (m) of this section not to exceed one hundred dollars ($100.00) for a first offense, five hundred dollars ($500.00) for a second offense within two (2) years and one thousand dollars ($1,000.00) for a third offense within three (3) years. Any administrative penalty assessed shall be paid to the board who shall remit the monies to the county treasurer to the credit of the public school fund of the county in which the violation occurred.

(p)

For purposes of this section, "methamphetamine precursor drug" means nonliquid ephedrine, pseudoephedrine or phenylpropanolamine or liquid products with ephedrine or pseudoephedrine as the sole active ingredient.

Section 2.

This act is effective July 1, 2005.

(END)

Speaker of the House

President of the Senate

Governor

TIME APPROVED: _________

DATE APPROVED: _________

I hereby certify that this act originated in the House.

Chief Clerk

1